Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Net loss	$ 352,662	$ 795,259
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	59,364	38,817
Net (gains) losses realized on the sale of securities and net credit losses recognized in operations	171,776	103,325
Unrealized (gains) losses on equity securities	(1,006,400)	(311,127)
Change in fair value of embedded derivative	265,846	(425,122)
(Accretion) amortization of investment securities, net	(497,386)	(236,651)
Deferred acquisition costs capitalized	(430,088)	(394,449)
Deferred acquisition costs amortized	1,046,775	1,059,975
Value of business acquired amortized	69,315	69,315
Interest credited on deposit type contracts	1,479,337	1,328,688
(Increase) decrease in operating assets: Investment income due and accrued	883,515	(525,563)
Reinsurance related assets	57,697	(772,248)
Deferred tax assets, net of valuation allowance	460,377	0
Other assets	(1,113,994)	(244,699)
Increase (decrease) in operating liabilities: Policyowner benefit reserves	4,042,362	3,414,010
Dividend accumulation	(14,756)	(3,513)
Advance premiums	28,455	(16,484)
Other liabilities	20,190	(1,532)
Accounts payable and accrued expenses	(1,047,323)	2,248,135
Net cash provided by operating activities	4,827,724	6,126,136
Cash Flows from investing activities:
Purchase of fixed income investments	(12,099,066)	(6,022,114)
Purchase of equity investments	(341,452)	(477,673)
Purchase of mortgage investments	(13,296,032)	(4,150,647)
Purchase of other invested assets	(165,197)	(810,545)
Proceeds from fixed income sales and repayments	9,172,094	3,528,290
Proceeds from equity sales	1,229,759	1,106,288
Proceeds from mortgage repayments	7,096,806	5,249,848
Proceeds from other invested assets	39,431	547,952
Increase in policy loans	(4,846)	9,615
Purchase of property, equipment and software	(43,695)	(209,659)
Net cash used in investing activities	(8,412,198)	(1,228,645)
Cash Flows from financing activities:
Receipts on deposit-type contracts	5,039,078	3,544,001
Withdrawals on deposit-type contracts	(5,944,736)	(6,389,402)
Proceeds received from issuance of common stock, net of costs of issuance	0	9,232
Net cash used in financing activities	(905,658)	(2,836,169)
Net increase (decrease) in cash and cash equivalents	(4,490,132)	2,061,322
Cash and Cash Equivalents:
Beginning	8,982,138	4,091,507
Ending	$ 4,492,006	$ 6,152,829